...
...
Next Story

Antimicrobial makers may need Centre’s nod before seeking licences

The Union health ministry has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, that would require manufacturers of antimicrobials to obtain central permission before they can apply to a state for a manufacturing licence

Published on: Nov 20, 2026, 07:58:30 IST
Advertisement

The Union health ministry has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, that would require manufacturers of antimicrobials to obtain central permission before they can apply to a state for a manufacturing licence.

India News
India News

The draft notification, G.S.R. 983(E) dated November 6, proposes to include antimicrobials in the definition of “new drug” under the rules, the ministry said in a statement on Thursday. Manufacturers would then need permission from the Central Licensing Authority (CLA) before applying for a manufacturing licence from the state licensing authority (SLA) concerned. “This is expected to strengthen central regulatory oversight and help ensure the quality, safety and efficacy of antimicrobial products,” the statement said.

The change would put a central check ahead of state licensing for antimicrobials. At present, state licensing authorities grant manufacturing licences for these products, and the amendment was prompted by concerns that some were cleared without adequate regulatory scrutiny, including studies such as bioavailability/bioequivalence and stability studies, according to persons aware of the matter.

The change will apply prospectively, according to a senior health ministry official aware of the matter, who asked not to be named. Licences already granted will remain valid, and existing licence holders will not have to reapply, the official said.

The official described the proposal as part of a wider push. “The proposal is intended to serve as an additional regulatory safeguard against antimicrobial resistance (AMR) by strengthening oversight of antimicrobial products and ensuring appropriate scrutiny of their quality, safety and efficacy before the grant of new manufacturing licences. The measure is part of the Government’s broader efforts to promote the responsible use of antimicrobials, safeguard patient safety and address the growing public health challenge of AMR,” the official said.

AMR is a major global public health concern and a priority requiring coordinated action. The G20 New Delhi Leaders’ Declaration also underscored the need to address it through a One Health approach.

The draft has been issued to invite objections and suggestions from stakeholders and the public within 30 days before the central government considers it for finalisation.

 
ABOUT THE AUTHOR
Rhythma Kaul

Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.

Get Latest News, breaking headlines, and top India News, and today real-time updates from across the nation. Stay informed on politics, government policies, crime, Today Weather, and major developments on Hindustan Times
Get Latest News, breaking headlines, and top India News, and today real-time updates from across the nation. Stay informed on politics, government policies, crime, Today Weather, and major developments on Hindustan Times
SHARE THIS ARTICLE ON
Notifications

Get breaking alerts directly from the newsroom

Notifications are on!You'll be notified when news breaks